Division of Reproductive Engineering, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan.
Division of Reproductive Engineering, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan.
Theriogenology. 2019 Sep 1;135:1-6. doi: 10.1016/j.theriogenology.2019.05.028. Epub 2019 Jun 4.
Superovulation technique is important to improve the efficiency of oocyte and animal production and reduce the number of oocyte donors. Previously, we have reported that the coadministration of inhibin antiserum (IAS) and equine chorionic gonadotropin (eCG) results in the production of >100 oocytes in a 4-week-old female C57BL/6 mice. It is well established that superovulation depends on the age of the female mice. However, detailed data regarding the ovulation of juvenile, mature, and aged female mice following the administration of IAS and eCG as well as the performance of reproductive technologies using oocytes have not yet been investigated. In the present study, we examined the effect of the age of female mice (3-50 weeks old) on the number of ovulated oocytes via the coadministration of IAS and eCG or eCG alone. Treatment with IAS plus eCG produced the maximum number of oocytes at 4 weeks of age. Moreover, IAS plus eCG produced more oocytes than eCG alone in mice aged between 3 and 5 weeks or 7 and 30 weeks. The fertilization and birth rates were similar between the two treatments at any age. Moreover, after vitrifying and warming the embryos, the survival and birth rates of two-cell embryos were similar between the two treatments. Subsequently, we examined the optimal ages of female mice (between 24 and 34 days) to obtain a high and stable number of oocytes. In mice aged between 24 and 32 days, IAS plus eCG induced the production of more eggs than eCG alone. Notably, the coadministration of IAS and eCG in mice aged between 25 and 31 days resulted in stable ovulation and high number of oocytes. Using the tip of the optimal female aged between 25 and 31 days old, we demonstrated an efficient production of embryos and offspring between homozygous knockout males and few females aged 26-28 days via in-vitro fertilization and embryo transfer. In summary, the coadministration of IAS and eCG resulted in a higher number of oocytes in juvenile, mature, and aged female mice. This treatment may be useful for the efficient production of homozygous mutant mice from a limited number of female mice.
超数排卵技术对于提高卵母细胞和动物生产效率、减少卵母细胞供体数量非常重要。以前,我们曾报道过,在 4 周龄的 C57BL/6 雌性小鼠中共同给予抑制素抗血清(IAS)和马绒毛膜促性腺激素(eCG)可产生>100 个卵母细胞。众所周知,超数排卵取决于雌性小鼠的年龄。然而,关于 IAS 和 eCG 给药后幼年、成熟和老年雌性小鼠的排卵情况以及使用卵母细胞的生殖技术的性能的详细数据尚未得到研究。在本研究中,我们通过共同给予 IAS 和 eCG 或单独给予 eCG 检查了雌性小鼠年龄(3-50 周龄)对排卵卵母细胞数量的影响。IAS 加 eCG 治疗可在 4 周龄时产生最多的卵母细胞。此外,在 3-5 周龄或 7-30 周龄的小鼠中,IAS 加 eCG 产生的卵母细胞多于单独使用 eCG。在任何年龄,两种处理的受精率和出生率相似。此外,在胚胎玻璃化和解冻后,两种处理的两细胞胚胎存活率和出生率相似。随后,我们检查了雌性小鼠的最佳年龄(24-34 天),以获得高而稳定的卵母细胞数量。在 24-32 天龄的小鼠中,IAS 加 eCG 诱导产生的卵母细胞多于单独使用 eCG。值得注意的是,在 25-31 天龄的小鼠中共同给予 IAS 和 eCG 导致排卵稳定且卵母细胞数量高。使用 25-31 天龄的最佳雌性尖的,我们通过体外受精和胚胎转移证明了来自少数 26-28 天龄的纯合子敲除雄性和雌性的高效胚胎和后代生产。总之,IAS 和 eCG 的共同给予可在幼年、成熟和老年雌性小鼠中产生更多的卵母细胞。这种治疗方法可能对从有限数量的雌性小鼠中高效生产纯合子突变体小鼠有用。